NO20054349L - Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi - Google Patents

Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi

Info

Publication number
NO20054349L
NO20054349L NO20054349A NO20054349A NO20054349L NO 20054349 L NO20054349 L NO 20054349L NO 20054349 A NO20054349 A NO 20054349A NO 20054349 A NO20054349 A NO 20054349A NO 20054349 L NO20054349 L NO 20054349L
Authority
NO
Norway
Prior art keywords
nemorubicin
therapy
radiation therapy
combined cancer
cancer therapy
Prior art date
Application number
NO20054349A
Other languages
English (en)
Inventor
Antonino Suarato
Maria Cristina Rosa Geroni
Maria Adele Pacciarini
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20054349L publication Critical patent/NO20054349L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives et morfolinyl-antracyklinderivat for anvendelse som radiosensibilisator, for administrering i kombinasjon med strålingsterapi, slik at det oppstår en synergistisk effekt.
NO20054349A 2003-03-18 2005-09-20 Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi NO20054349L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075781 2003-03-18
PCT/EP2004/050246 WO2004082579A2 (en) 2003-03-18 2004-03-03 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors

Publications (1)

Publication Number Publication Date
NO20054349L true NO20054349L (no) 2005-10-11

Family

ID=33016931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054349A NO20054349L (no) 2003-03-18 2005-09-20 Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi

Country Status (8)

Country Link
EP (1) EP1603575A2 (no)
AU (1) AU2004222526A1 (no)
BR (1) BRPI0408494A (no)
CA (1) CA2519289A1 (no)
MX (1) MXPA05009851A (no)
NO (1) NO20054349L (no)
RU (1) RU2005132175A (no)
WO (1) WO2004082579A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298891A1 (en) * 2005-09-16 2009-12-03 Government Of The Us, As Represented By The Secretady Of Health And Human Services Methods of Treating or Preventing Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents
ES2552718T3 (es) 2007-05-11 2015-12-01 Nerviano Medical Sciences S.R.L. Composición farmacéutica de una antraciclina
EP2240495B1 (en) 2008-02-01 2015-07-15 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
US8900589B2 (en) 2008-07-15 2014-12-02 Genetech, Inc. Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
CN103270043B (zh) 2010-12-02 2015-12-16 内尔维阿诺医学科学有限公司 用于制备吗啉基蒽环衍生物的方法
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
ES2735375T3 (es) * 2014-11-05 2019-12-18 Nerviano Medical Sciences Srl Derivados funcionalizados de morfolinil antraciclina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) * 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
GB2296495B (en) * 1994-12-23 1998-04-15 Erba Carlo Spa Anthracycline derivatives
GB2315067B (en) * 1996-07-11 2000-02-16 Pharmacia Spa Morpholinyl anthracycline derivatives
KR100968657B1 (ko) * 2002-04-02 2010-07-06 네르비아노 메디칼 사이언시스 에스.알.엘. 치환된 아크릴로일 디스타마이신 유도체 및 방사선요법을포함하는 조합 종양 치료법

Also Published As

Publication number Publication date
EP1603575A2 (en) 2005-12-14
BRPI0408494A (pt) 2006-04-04
AU2004222526A1 (en) 2004-09-30
MXPA05009851A (es) 2005-12-06
WO2004082579A3 (en) 2004-11-11
WO2004082579A2 (en) 2004-09-30
CA2519289A1 (en) 2004-09-30
RU2005132175A (ru) 2006-01-27

Similar Documents

Publication Publication Date Title
NO20054349L (no) Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi
MY141196A (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
DK1565471T3 (da) Quionolinylpyrazoler
DK1689724T3 (da) Quinazolinonforbindelser som anticancermidler
CY1110013T1 (el) Συνδυασμοι για θεραπεια πολλαπλου μυελωματος
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
AR035293A1 (es) Composicion oftalmica.
CY1108430T1 (el) Χρηση ανταγωνιστων διαυλου νευρωνικου νατριου μαζι με αμιτραζ για τον ελεγχο εκτοπαρασιτων σε ομοιοθερμικα ζωα
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
ATE348630T1 (de) Verminderung der nebenwirkungen der chemotherapie in krebspatienten
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
UY26422A1 (es) Método para administrar un inhibidor de fosfodiesterasa 4
DK1523473T3 (da) Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
CL2008002465A1 (es) Composición farmacéutica anhidra tópica, que comprende derivados de niacina y un portador aceptable, su aplicacón permite un bienestar sexual mejorado.
ECSP066836A (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
PA8576701A1 (es) Derivados de quinazolina
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
PA8589401A1 (es) Derivados de indolilo
TH68734A (th) วิธีทำให้เกิดการเสริมฤทธิ์กัน และสารผสมเพื่อการบำบัดมะเร็ง
WO2004038404A3 (en) Method for optimizing therapeutic efficacy of nemorubicin